Drug Resistance in Epilepsy: Clinical Impact, Potential Mechanisms, and New Innovative Treatment Options

Epilepsy is a chronic neurologic disorder that affects over 70 million people worldwide. Despite the availability of over 20 antiseizure drugs (ASDs) for symptomatic treatment of epileptic seizures, about one-third of patients with epilepsy have seizures refractory to pharmacotherapy. Patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Löscher, Wolfgang, Potschka, Heidrun, Sisodiya, Sanjay M., Vezzani, Annamaria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society for Pharmacology and Experimental Therapeutics 2020
Materias:
Review Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7300324/
https://www.ncbi.nlm.nih.gov/pubmed/32540959
http://dx.doi.org/10.1124/pr.120.019539

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7300324/
https://www.ncbi.nlm.nih.gov/pubmed/32540959
http://dx.doi.org/10.1124/pr.120.019539

Ejemplares similares